HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protective effect of ilomastat on trinitrobenzenesulfonic acid-induced ulcerative colitis in rats.

AbstractAIM:
To evaluate the protective effects of ilomastat, an exogenous matrix metalloproteinase (MMP) inhibitor, on trinitrobenzenesulfonic acid (TNB)-induced ulcerative colitis (UC) in rats.
METHODS:
Male SD rats were randomly divided into model group, protective groups A and B, and normal control group. Rats in the model group received only intra-colonic TNB. Rats in the protective groups A and B received intra-peritoneal ilomastat of 10 mg/kg and 20 mg/kg, respectively, beside TNB. Rats in the normal control group received only intra-colonic normal saline. After 3 wk, segments of colon were obtained. RT-PCR and immunohistochemistry were used to examine the expression of MMP-1 and TIMP-1. Hematoxylin-eosin (HE) staining was used for pathological study.
RESULTS:
The model of UC was successfully induced in rats. Inflammation of colonic mucosa greatly improved in protective groups A and B. Expression of MMP-1 and TIMP-1 in the model group, protective groups A and B was significantly higher than that in the normal control group (P < 0.0001) with MMP-1 expression increased more significantly than TIMP-1 expression. Expression of MMP-1 in protective groups A and B was significantly lower than that in the model group (P < 0.0001) . Expression of MMP-1 in protective group B was significantly lower than that in protective group A (P < 0.0001).
CONCLUSION:
Ilomastat improves TNB-induced UC in rats by inhibiting the MMP-1 activity.
AuthorsYing-De Wang, Wei Wang
JournalWorld journal of gastroenterology (World J Gastroenterol) Vol. 14 Issue 37 Pg. 5683-8 (Oct 07 2008) ISSN: 1007-9327 [Print] United States
PMID18837084 (Publication Type: Journal Article)
Chemical References
  • Anti-Inflammatory Agents
  • Gastrointestinal Agents
  • Hydroxamic Acids
  • Indoles
  • Matrix Metalloproteinase Inhibitors
  • Protease Inhibitors
  • RNA, Messenger
  • Tissue Inhibitor of Metalloproteinase-1
  • Trinitrobenzenesulfonic Acid
  • Matrix Metalloproteinase 1
  • ilomastat
Topics
  • Animals
  • Anti-Inflammatory Agents (pharmacology)
  • Colitis, Ulcerative (chemically induced, enzymology, prevention & control)
  • Colon (drug effects, enzymology, pathology)
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Gastrointestinal Agents (pharmacology)
  • Hydroxamic Acids
  • Immunohistochemistry
  • Indoles (pharmacology)
  • Male
  • Matrix Metalloproteinase 1 (genetics, metabolism)
  • Matrix Metalloproteinase Inhibitors
  • Protease Inhibitors (pharmacology)
  • RNA, Messenger (metabolism)
  • Rats
  • Rats, Sprague-Dawley
  • Reverse Transcriptase Polymerase Chain Reaction
  • Tissue Inhibitor of Metalloproteinase-1 (metabolism)
  • Trinitrobenzenesulfonic Acid

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: